As of 2025-07-01, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 13.9x | 13.2x |
| Forward P/E multiples | 13.3x - 18.1x | 17.1x |
| Fair Price | (9.86) - (10.09) | (10.52) |
| Upside | -164.6% - -166.2% | -169.0% |
| Date | EV/EBITDA |